Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost vs. Travoprost for Glaucoma
NCT00347802Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Modality
- Orthosteric Ligands, Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of bimatoprost, travoprost in Glaucoma, ocular hypertension, sponsored by Janssen Pharmaceutical. Status: completed.
02
Drugs
bimatoprosttravoprost
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00347802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347802.